Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study
European Journal of Nuclear Medicine · 1991-05 · 18 (5) · 308-316
DOI: 10.1007/bf02285457 ↗At a glance
Klinische Studie in European Journal of Nuclear Medicine, 1991-05. Written by S L Fielding and 5 co-authors. Institution: Physics Department, Royal Marsden Hospital, Sutton, Surrey, UK. Major MEDLINE topics: Radiometry. Cited 57 times so far (Crossref); 16 references.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Physics Department, Royal Marsden Hospital, Sutton, Surrey, UK.
Cite
APA
Fielding, S. L., Flower, M. A., Ackery, D., Kemshead, J. T., Lashford, L. S., & Lewis, I. (1991). Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study. European Journal of Nuclear Medicine, 18(5), 308-316. https://doi.org/10.1007/bf02285457
Vancouver
Fielding SL, Flower MA, Ackery D, Kemshead JT, Lashford LS, Lewis I. Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study. European Journal of Nuclear Medicine. 1991;18(5):308-316. doi:10.1007/bf02285457
BibTeX
@article{Fielding1991,
author = {Fielding, S L and Flower, M A and Ackery, D and Kemshead, J T and Lashford, L S and Lewis, I},
title = {Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study},
journal = {European Journal of Nuclear Medicine},
year = {1991},
volume = {18},
number = {5},
pages = {308--316},
doi = {10.1007/bf02285457}
}
EUVIMED